CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Winnergy Medical PCL is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Winnergy Medical PCL
Wang Thong Lang
Phone: +66 27250888p:+66 27250888 BANGKOK, 10310  Thailand Ticker: WINMEDWINMED

Business Summary
Winnergy Medical Public Company Limited is a Thailand-based company, which is engaged in the distribution of medical and diagnostics equipment. The Company imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The Company operates through two segments: Medical products and Other products. The Company's businesses include Trading business and Laboratory services. Its Trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The Company imports cytology and molecular microbiology products from Hologic Co., Ltd. from the United States. The Company imports products related to blood donation from Haemonetics Company of the United States. It distributes blood diagnostics products from Grifols, Spain. The Company also distributes clinical products, including reagents, such as Clinical cell separation, In vitro diagnostic (IVD) and Analyte specific reagents (ASR).

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board TerdsakRojsurakitti 65 9/27/2019 9/27/2019
Chief Executive Officer, Executive Director NanthiyaDarakananda 52 1/31/2018 1/31/2018
Chief Financial Officer, Executive Director RachanArayawongchai 49 8/16/2021 6/1/2020
9 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 400,000,000 (As of 12/31/2023)
Stock Exchange: BAK
Fax Number: +66 27250880


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024